Young Cw
Impact in
-
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Acute Myeloid Leukemia Research
Papers in
-
- Biochemical and Molecular Research 8
- Cancer therapeutics and mechanisms 5
- Oncology 8
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Gerald Schochetman (1 shared paper)Burchenal Jh (4 shared papers)Casper Es (5 shared papers)Arlin Za (3 shared papers)Raymond Raymond (1 shared paper)Edward Miller (2 shared papers)B Clarkson (1 shared paper)Gralla Rj (3 shared papers)
- Journals
- MiJo (1 paper)PubMed (27 papers)
- Partner nations
- United States
In The Last Decade
Young Cw
28 papers receiving 407 citations
Peers
Comparison fields: 5 of 84
- Oncology 191
- Hematology 56
- Molecular Biology 212
- Genetics 32
- Cancer Research 43
Countries citing papers authored by Young Cw
This map shows the geographic impact of Young Cw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young Cw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young Cw more than expected).
Fields of papers citing papers by Young Cw
This network shows the impact of papers produced by Young Cw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young Cw. The network helps show where Young Cw may publish in the future.
Co-authors
The 25 scholars most cited alongside Young Cw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of DNA synthesis by hydroxyurea: structure-activity relationships. | 1967 | 85 |
| 2 | The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine). | 1960 | 50 |
| 3 | Phase I trial of homoharringtonine administered as a 5-day continuous infusion. | 1983 | 28 |
| 4 | Application of biochemical modulation with a therapeutically inactive modulating agent in clinical trials of cancer chemotherapy. | 1985 | 25 |
| 5 | Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside. | 1979 | 22 |
| 6 | Phase I study of 6-diazo-5-oxo-L-norleucine (DON). | 1980 | 22 |
| 7 | Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives. | 1986 | 21 |
| 8 | Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia. | 1982 | 21 |
| 9 | Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine. | 1981 | 20 |
| 10 | Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia. | 1982 | 20 |
| 11 | The clinical evaluation of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in solid tumors in adults: a progress report. | 1960 | 18 |
| 12 | Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU). | 1985 | 18 |
| 13 | Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II). | 1980 | 16 |
| 14 | The role of generalized pain and pain behavior in tender point scores in fibromyalgia. | 2000 | 15 |
| 15 | Revision of the crane fly genus Dicranoptycha in North America. | 1987 | 12 |
| 16 | Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with non-small cell carcinoma of the lung. | 1981 | 12 |
| 17 | Phase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma. | 1981 | 11 |
| 18 | Comparative aspects of the pharmacology of the antimetabolites. | 1967 | 9 |
| 19 | Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule. | 1980 | 9 |
| 20 | Phase I trial of PALA. | 1980 | 9 |
About Young Cw
Young Cw is a scholar working on Molecular Biology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health, having authored 29 papers that have together received 482 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (8 papers), Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (5 papers), Acute Lymphoblastic Leukemia research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Glioma Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Oncology (191 citations), Hematology (56 citations), Molecular Biology (212 citations), Genetics (32 citations) and Cancer Research (43 citations). Young Cw has collaborated with scholars based in United States. Frequent co-authors include Gerald Schochetman, Burchenal Jh, Casper Es, Arlin Za, Raymond Raymond, Edward Miller, B Clarkson, Gralla Rj, Golbey Rb and Jeremy A. Roberts. Their work appears in journals such as MiJo and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.